PT87022A - Process for the preparation of plasmodium falciparum merozoite antigen peptides and of immunogenic compositions containing the same - Google Patents

Process for the preparation of plasmodium falciparum merozoite antigen peptides and of immunogenic compositions containing the same

Info

Publication number
PT87022A
PT87022A PT87022A PT8702288A PT87022A PT 87022 A PT87022 A PT 87022A PT 87022 A PT87022 A PT 87022A PT 8702288 A PT8702288 A PT 8702288A PT 87022 A PT87022 A PT 87022A
Authority
PT
Portugal
Prior art keywords
immunogenic compositions
polypeptides
preparation
same
compositions containing
Prior art date
Application number
PT87022A
Other languages
English (en)
Other versions
PT87022B (pt
Inventor
Ulrich Certa
Reiner Gentz
Bela Takacs
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT87022A publication Critical patent/PT87022A/pt
Publication of PT87022B publication Critical patent/PT87022B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT87022A 1987-03-19 1988-03-18 Processo para a preparacao de peptidos antigenicos de merozoito de plasmodium falciparum e de composicoes imunogenicas que os contem PT87022B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878706599A GB8706599D0 (en) 1987-03-19 1987-03-19 Plasmodium falciparum merozoite antigen peptides

Publications (2)

Publication Number Publication Date
PT87022A true PT87022A (pt) 1988-04-01
PT87022B PT87022B (pt) 1992-06-30

Family

ID=10614280

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87022A PT87022B (pt) 1987-03-19 1988-03-18 Processo para a preparacao de peptidos antigenicos de merozoito de plasmodium falciparum e de composicoes imunogenicas que os contem

Country Status (17)

Country Link
US (1) US5238836A (pt)
EP (1) EP0283829B1 (pt)
JP (1) JP2567024B2 (pt)
AT (1) ATE92526T1 (pt)
AU (1) AU613344B2 (pt)
DE (1) DE3882755D1 (pt)
DK (1) DK84388A (pt)
ES (1) ES2058156T3 (pt)
GB (1) GB8706599D0 (pt)
HU (1) HU211581A9 (pt)
IE (1) IE62252B1 (pt)
IL (1) IL85724A (pt)
MY (1) MY103217A (pt)
NZ (1) NZ223860A (pt)
PH (1) PH25320A (pt)
PT (1) PT87022B (pt)
ZA (1) ZA881775B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0309746A1 (de) * 1987-09-08 1989-04-05 F. Hoffmann-La Roche Ag Antimalaria-Vakzine
US5225534A (en) * 1987-09-08 1993-07-06 Hoffmann-La Roche Inc. Recombinant malarial polypeptides
GB9002512D0 (en) * 1990-02-05 1990-04-04 3I Res Expl Ltd Polypeptides and dna encoding same
AUPO517897A0 (en) * 1997-02-19 1997-04-11 Csl Limited Chelating immunostimulating complexes
ZA981370B (en) * 1997-02-20 1998-09-07 Cerberus Developments Bv Method and apparatus for continuous flow isoelectric focusing for purifying biological substances
EP1754717A1 (en) * 2005-08-19 2007-02-21 Université de Lausanne Antigenic peptides and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK79985A (da) * 1984-02-22 1985-08-23 Wellcome Found Kloning af dna for protozoelle antigener og dets anvendelse
US4569794A (en) * 1984-12-05 1986-02-11 Eli Lilly And Company Process for purifying proteins and compounds useful in such process
EP0254862A1 (en) * 1986-06-26 1988-02-03 BEHRINGWERKE Aktiengesellschaft Vaccines against protozoan parasites
US4735799A (en) * 1987-01-14 1988-04-05 Patarroyo Manuel E Malaria vaccine
CA1340522C (en) * 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification

Also Published As

Publication number Publication date
PH25320A (en) 1991-04-30
AU613344B2 (en) 1991-08-01
IL85724A0 (en) 1988-08-31
DK84388A (da) 1988-09-20
HU211581A9 (en) 1995-12-28
PT87022B (pt) 1992-06-30
US5238836A (en) 1993-08-24
IE62252B1 (en) 1995-01-11
DE3882755D1 (de) 1993-09-09
JP2567024B2 (ja) 1996-12-25
NZ223860A (en) 1991-05-28
JPS63275599A (ja) 1988-11-14
MY103217A (en) 1993-05-29
GB8706599D0 (en) 1987-04-23
AU1307788A (en) 1988-09-22
EP0283829A1 (de) 1988-09-28
ZA881775B (en) 1988-09-19
IL85724A (en) 1994-11-28
IE880809L (en) 1988-09-19
EP0283829B1 (de) 1993-08-04
DK84388D0 (da) 1988-02-18
ATE92526T1 (de) 1993-08-15
ES2058156T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
RU2004115492A (ru) Внутриклеточный домен белка her-2/neu для предупреждения или лечения малигнизаций
PT87022A (pt) Process for the preparation of plasmodium falciparum merozoite antigen peptides and of immunogenic compositions containing the same
Lopez et al. Characterization of SPf (66) n: a chimeric molecule used as a malaria vaccine
SJÖLANDER et al. Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA
CA2113562A1 (en) Poultry mycoplasma antigens, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same
WO1997039029A3 (en) An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
US4956449A (en) Immunologically active synthetic peptides useful for preparing an antimalarial vaccine
KR920006503A (ko) 살모넬라 백신 균주의 표면에 면역원성 말라리아 항원을 발현할수 있는 재조합 발현 벡터
GB2230009B (en) Plasmodium merozoite rhoptries antigen and derivatives thereof
EP0433378B1 (en) ALLELIC VARIANTS OF $i(PLASMODIUM FALCIPARUM) MEROZOITE SURFACE ANTIGEN
KR890000106A (ko) 원생성 기생충 예방용 백신
HU896767D0 (en) Elimera tenella vaccine
AU638216C (en) Allelic variants of plasmodium falciparum merozoite surface antigen
TH4338A (th) พลาสโมเดียม ฟาลซิพารุมที่ไร้เพศระยะซึ่งอยู่ในเลือด
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911210

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19980630